Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.

[1]  S. Withers,et al.  Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen. , 2008, Biochemistry.

[2]  Eric Verdin,et al.  Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. , 2008, Journal of medicinal chemistry.

[3]  Ying Sun,et al.  Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. , 2008, Journal of medicinal chemistry.

[4]  R. Dwek,et al.  Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. , 2008, Anti-cancer agents in medicinal chemistry.

[5]  J. B. Garrison,et al.  Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. , 2007, Cancer research.

[6]  G. Fleet,et al.  Looking glass inhibitors: synthesis of a potent naringinase inhibitor l-DIM [1,4-dideoxy-1,4-imino-l-mannitol], the enantiomer of DIM [1,4-dideoxy-1,4-imino-d-mannitol] a potent α-d-mannosidase inhibitor , 2007 .

[7]  L. Juillerat-Jeanneret,et al.  Synthesis of New Pyrrolidine Derivatives as Inhibitors of a-Mannosidase and of the Growth of Human Glioblastoma Cells , 2006 .

[8]  M. Pfaffl,et al.  Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR , 2006, Biotechnology Letters.

[9]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[10]  A. Ballestrero,et al.  Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells , 2005, Clinical Cancer Research.

[11]  L. Juillerat-Jeanneret,et al.  Functionalized pyrrolidines inhibit alpha-mannosidase activity and growth of human glioblastoma and melanoma cells. , 2005, Journal of medicinal chemistry.

[12]  L. Devy,et al.  Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor , 2004, Clinical Cancer Research.

[13]  A. Helenius,et al.  Roles of N-linked glycans in the endoplasmic reticulum. , 2004, Annual review of biochemistry.

[14]  D. Kuntz,et al.  Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms. , 2003, Biochemistry.

[15]  P. Vogel,et al.  Synthesis and glycosidase inhibitory activities of 2-(aminoalkyl)pyrrolidine-3,4-diol derivatives. , 2003, Bioorganic & medicinal chemistry.

[16]  N. Asano.  Glycosidase inhibitors: update and perspectives on practical use. , 2003, Glycobiology.

[17]  E. Trombetta,et al.  The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. , 2003, Glycobiology.

[18]  R. Dwek,et al.  Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation. , 2003, The Biochemical journal.

[19]  H. Freeze.  Human disorders in N-glycosylation and animal models. , 2002, Biochimica et biophysica acta.

[20]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Vogel,et al.  An Efficient Combinatorial Method for the Discovery of Glycosidase Inhibitors , 2002, Chembiochem : a European journal of chemical biology.

[22]  Luyi Guo,et al.  Synthesis and mannosidase inhibitory activity of 3-benzyloxymethyl analogs of swainsonine , 2001 .

[23]  E. Hembre,et al.  Synthesis and mannosidase inhibitory activity of 6- and 7-substituted analogs of swainsonine , 2001 .

[24]  A. Ballestrero,et al.  Reverse‐transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination , 2001, Cancer.

[25]  P. Vogel,et al.  Derivatives of (2R, 3R, 4S)-2-aminomethylpyrrolidine-3,4-diol are selective α-mannosidase inhibitors , 2001 .

[26]  D. Kuntz,et al.  Structure of Golgi α‐mannosidase II: a target for inhibition of growth and metastasis of cancer cells , 2001, The EMBO journal.

[27]  C. Belka,et al.  Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL , 2001, Oncogene.

[28]  C. Barberis,et al.  Rapid access to N-Boc phenylglycine derivatives via benzylic lithiation reactions , 2001 .

[29]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[30]  J. Dennis,et al.  Glycoprotein glycosylation and cancer progression. , 1999, Biochimica et biophysica acta.

[31]  A. Herscovics,et al.  Importance of glycosidases in mammalian glycoprotein biosynthesis. , 1999, Biochimica et biophysica acta.

[32]  A. Herscovics,et al.  Substrate specificities of recombinant murine Golgi alpha1, 2-mannosidases IA and IB and comparison with endoplasmic reticulum and Golgi processing alpha1,2-mannosidases. , 1998, Glycobiology.

[33]  S. Withers,et al.  Identification of the Active Site Nucleophile in Jack Bean α-Mannosidase Using 5-Fluoro-β-l-Gulosyl Fluoride* , 1998, The Journal of Biological Chemistry.

[34]  W. Shieh,et al.  Asymmetric Synthesis of N-Substituted alpha-Aminobenzlactam via Crystallization-Induced Asymmetric Transformation of Covalent Diastereomer. , 1997, The Journal of organic chemistry.

[35]  S. Withers,et al.  Human lysosomal and jack bean alpha-mannosidases are retaining glycosidases. , 1997, Biochemical and biophysical research communications.

[36]  P. Goss,et al.  Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  D C Linch,et al.  Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. , 1996, Blood.

[38]  J Hermans,et al.  Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Stefano Cicchi,et al.  Assignment of the Absolute Configuration of Natural Lentiginosine by Synthesis and Enzymic Assays of Optically Pure (+) and (-)-Enantiomers , 1995 .

[40]  J. Dennis,et al.  Inhibitors of carbohydrate processing: A new class of anticancer agents. , 1995, Clinical Cancer Research.

[41]  R. Spiro,et al.  Demonstration that a kifunensine-resistant alpha-mannosidase with a unique processing action on N-linked oligosaccharides occurs in rat liver endoplasmic reticulum and various cultured cells. , 1993, The Journal of biological chemistry.

[42]  K. Olden,et al.  The potential importance of swainsonine in therapy for cancers and immunology. , 1991, Pharmacology & therapeutics.

[43]  M. Oken,et al.  bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. , 1989, The New England journal of medicine.

[44]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[45]  F. Wudl,et al.  Bis(ethylenedioxy)tetrathiafulvalene: the first oxygen-substituted tetrathiafulvalene , 1989 .

[46]  N. Miyaura,et al.  Palladium-catalyzed inter- and intramolecular cross-coupling reactions of B-alkyl-9-borabicyclo[3.3.1]nonane derivatives with 1-halo-1-alkenes or haloarenes. Syntheses of functionalized alkenes, arenes, and cycloalkenes via a hydroboration-coupling sequence , 1989 .

[47]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[48]  B. Winchester,et al.  Synthesis from d-mannose of 1,4-dideoxy-1,4-imino-l-ribitol and of the α-mannosidase inhibitor 1,4-dideoxy-1,4-imino-d-talitol , 1988 .

[49]  E. Egert,et al.  Optically Active α-Arylglycine Esters by Friedel-Crafts Alkylation with the Chiral Cation of the Bislactim Ether of cyclo-(L-Val-Gly)† , 1987 .

[50]  K. Nakahara,et al.  Studies of an immunomodulator, swainsonine. II. Effect of swainsonine on mouse immunodeficient system and experimental murine tumor. , 1985, The Journal of antibiotics.

[51]  S. Hakomori,et al.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. , 1985, Cancer research.

[52]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[53]  A. Elbein,et al.  Castanospermine, a tetrahydroxylated alkaloid that inhibits β-glucosidase and β-glucocerebrosidase , 1983 .

[54]  C. Huxtable,et al.  Inhibition of lysosomal alpha-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens. , 1980, The Biochemical journal.

[55]  G. Just,et al.  β-Lactams. V. The synthesis of D,L-4-hydroxymethylnocardicin A (17N), D,L-4-hydroxymethyl-N-phenylacetylnocardicinic acid (8N-f), and their α-epimers 17U and 8U-f , 1979 .